Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Debt Ratio (2024 - 2026)

Updated

Revium Rx's (RVRC) Debt Ratio came in at 0.00 for Q2 2026.

Analysis

Revium Rx (RVRC) Debt Ratio (2024 - 2026) Analysis & Trends

  • In prior years, Revium Rx's Debt Ratio was 0.00 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.24
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.52
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.42
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.31
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.00
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.60
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.53
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Revium Rx 86.84 Mn 86.00 Mn - 0.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00
Dec 31, 2025 0.00
Dec 31, 2024 0.00
API Access

Revium Rx Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=RVRC&period=max&api_key=YOUR_API_KEY